Takeda to take back Prostap in the UK and Ireland
This article was originally published in Scrip
Executive Summary
Takeda is to take over the marketing of Prostap (sustained-release leuprorelin acetate) in the UK and Ireland later this year following the expiry of a long-standing licence agreement with Wyeth.